Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03857958
Other study ID # 1812-098-996
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 15, 2019
Est. completion date June 30, 2021

Study information

Verified date April 2019
Source Seoul National University Hospital
Contact Min su You, MD
Phone 82-2-2072-2228
Email bass105@hanmail.net
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study was to compare the difference in the stent patency duration between side-by-side fully covered self-expanding metal stents (SEMS) and side-by-side plastic stents in patients with malignant hilar biliary obstruction.


Description:

In the case of distal common bile duct obstruction, the SEMS was reported to be clinically superior to the plastic stent in previous studies. However, there are few studies comparing the two methods in patients with malignant hilar biliary obstruction. In contrast to the distal common bile duct obstruction, the advantage of plastic stents over SEMSs exists, and plastic stents are used commonly in real clinical practice.


Recruitment information / eligibility

Status Recruiting
Enrollment 54
Est. completion date June 30, 2021
Est. primary completion date December 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria:

- Unresectable malignant hilar biliary stricture requiring biliary drainage through endoscopic procedure

Exclusion Criteria:

- If endoscopy is not possible based on the judgement of the researcher

- Life expectancy less than 6 months

- Acute cholecystitis

- Previous history of percutaneous transhepatic biliary drainage

- Previous history of metal stent placement for malignant biliary stricture

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
endoscopic retrograde cholangio-pancreatography
In patients who were identified to have malignant hilar biliary obstruction, bilateral stents insertion is attempted via ERCP. There will be two groups divided by stent material; FCSEMS and Plastic stent.

Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul

Sponsors (2)

Lead Sponsor Collaborator
Seoul National University Hospital Taewoong Medical Co., Ltd.

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Duration of stent patency The period from the insertion of the stent to the point at which stent revision is required. 9 months after randomization.
See also
  Status Clinical Trial Phase
Completed NCT02916199 - Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method N/A
Completed NCT05068739 - Needle Knife Fistulotomy Versus Partial Ampullary Endoscopic Mucosal Resection for Difficult Biliary Cannulation N/A
Recruiting NCT06053333 - Social Determinants of Health in Hepatobiliary Cancer Patients
Not yet recruiting NCT03195075 - Endoscopic Ultrasonography Guided Biliary Drainage N/A
Completed NCT03112668 - Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners N/A
Completed NCT02265341 - Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions Phase 2
Recruiting NCT04704661 - Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial Phase 1
Recruiting NCT05334069 - Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection